A Conceptual Discussion About the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
23 01 2021
Historique:
received: 20 04 2020
accepted: 28 05 2020
pubmed: 31 5 2020
medline: 28 1 2021
entrez: 31 5 2020
Statut: ppublish

Résumé

To date, no specific estimate of R0 for SARS-CoV-2 is available for healthcare settings. Using interindividual contact data, we highlight that R0 estimates from the community cannot translate directly to healthcare settings, with pre-pandemic R0 values ranging 1.3-7.7 in 3 illustrative healthcare institutions. This has implications for nosocomial COVID-19 control.

Identifiants

pubmed: 32473007
pii: 5849067
doi: 10.1093/cid/ciaa682
pmc: PMC7314155
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-143

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Emerg Infect Dis. 2020 Jul;26(7):1470-1477
pubmed: 32255761
BMC Med. 2020 Jul 30;18(1):240
pubmed: 32727547
Int J Infect Dis. 2020 Apr;93:201-204
pubmed: 32097725
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Infect Control Hosp Epidemiol. 2015 Mar;36(3):254-60
pubmed: 25695165
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
BMC Infect Dis. 2016 Aug 09;16:395
pubmed: 27507065
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
PLoS One. 2015 Jul 15;10(7):e0133203
pubmed: 26176549
PeerJ. 2015 Dec 17;3:e1505
pubmed: 26713252
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
Sci Rep. 2018 Jan 26;8(1):1686
pubmed: 29374222

Auteurs

Laura Temime (L)

MESuRS laboratory, Conservatoire national des arts et métiers, Paris, France.
PACRI Unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France.

Marie-Paule Gustin (MP)

Institute of Pharmaceutic and Biological Sciences, University Claude Bernard Lyon 1, Villeurbanne, France.
Emerging Pathogens Laboratory-Fondation Mérieux, International Center for Infectiology Research (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon, France.

Audrey Duval (A)

Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France.
Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France.

Niccolò Buetti (N)

UPRES-EA 7449 REPERES "Recherche en Pharmaco-Epidémiologie et Recours aux Soins" - EHESP - Université de Rennes, Rennes, France.

Pascal Crépey (P)

Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France.

Didier Guillemot (D)

Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France.
Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France.
AP-HP Paris Saclay, Public Health, Medical Information, Clinical research, Le Kremlin-Bicêtre, France.

Rodolphe Thiébaut (R)

INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
INRIA SISTM team, Talence, France.
Vaccine Research Institute, Créteil, France.

Philippe Vanhems (P)

Emerging Pathogens Laboratory-Fondation Mérieux, International Center for Infectiology Research (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon, France.
Service d'Hygiène, Epidémiologie et Prévention, Hospices Civils de Lyon, F-69437, Lyon, France.
Inserm, F CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France.

Jean-Ralph Zahar (JR)

IAME, UMR1137, Inserm, Univ. Paris 13, Sorbonne Paris Cité, Paris, France.
Service de Microbiologie Clinique et Unité de Contrôle et de Prévention du Risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, Bobigny, France.

David R M Smith (DRM)

MESuRS laboratory, Conservatoire national des arts et métiers, Paris, France.
Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France.
Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France.

Lulla Opatowski (L)

Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France.
Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH